Verinata Health Revenue and Competitors
Estimated Revenue & Valuation
- Verinata Health's estimated annual revenue is currently $6M per year.
- Verinata Health's estimated revenue per employee is $301,200
Employee Data
- Verinata Health has 20 Employees.
- Verinata Health grew their employee count by 0% last year.
Verinata Health's People
| Name | Title | Email/Phone |
|---|
Verinata Health Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 211 | 12% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 64 | -7% | N/A | N/A |
#8 | $61.2M | 215 | 8% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Verinata Health?
Artemis Health is now Verinata Health. http://www.linkedin.com/company/verinata-health-inc- www.verinata.com -------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------
keywords:N/A
N/A
Total Funding
20
Number of Employees
$6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Verinata Health News
2022-04-17 - Global Newborn and Prenatal Genetic Testing Market Future ...
Perkin Elmer, Ariosa Diagnostics, Agilent Technologies, Inc., Verinata Health, Illumina, Inc., Sequenom, Inc., CapitalBio MedLab, Natera,...
2022-03-22 - Actress Katy Stoll Claims Covid-19 Vaccines "Significantly ...
The National Institutes of Health revealed in January 2022 that COVID-19 vaccines ... Source: Verinata Health, an Illumina Company YouTube.
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.7M | 20 | -5% | N/A |
#2 | $4.1M | 20 | -13% | N/A |
#3 | $3.6M | 20 | -33% | N/A |
#4 | $2M | 20 | N/A | N/A |
#5 | $2M | 20 | N/A | N/A |